Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT)

Bone Marrow Transplantation

Volumn 30, Issue 11, 2002, Pages 717-723

  Corvo R ^a   Lamparelli, T ^a   Bruno, B ^a   Barra, S ^a   Van Lint, M T ^a   Vitale, V ^a   Bacigalupo, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Bone marrow transplant; Total body irradiation; Unrelated donor

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DONOR; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LEUKEMIA; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; SURVIVAL RATE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; DOSE FRACTIONATION; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; WHOLE-BODY IRRADIATION;

EID: 0036903579     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703701     Document Type: Article

References (23)

1. Armitage JO. Bone marrow transplantation. New Engl J Med 1994; 330: 827-838.
2. Anasetti C, Petersdorf EW, Martin PJ et al. Improving availability and safety of unrelated donor transplants. Curr Opinion Oncol 2000; 12: 121-126.
3. Sierra J, Storer B, Hansen JA et al. Unrelated donor marrow transplantation for acute myeloid leukaemia: an update of the Seattle experience. Bone Marrow Transplant 2000; 26: 397-404.
4. Dini G, Lamparelli T, Rondelli R et al. Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 1998; 102: 544-552.
5. Gustafsson A, Renberger M, Winiarski J, Ringden O. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 2000; 25:1059-1065.
6. Lamparelli T, Van Lint MT, Gualandi F et al. Bone marrow transplantation for chronic myeloid leukaemia (CML) from unrelated and sibling donors: single centre experience. Bone Marrow Transplant 1997; 20: 1057-1062.
7. Hartman AR, William SF, Dillon JJ. Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplant 1998; 22: 439-443.
8. Shank B. Total body irradiation for bone or stem cell transplantation. Cancer Invest 1998; 16: 397-404.
9. Vitale V, Corvò R, Frassoni F et al. Allogeneic marrow transplantation in patients with acute and chronic myeloid leukaemia: influence of total body irradiation dose and graft-versus-host disease on relapse rate. Bull Cancer/Radiother 1991; 78: 207-216.
10. Wheldon TE, Barrett A. Radiobiological modelling of the treatment of leukaemia by total body irradiation. Radioth Oncol 2001; 58: 227-233.
11. Bieri S, Helg C, Chapuis B, Miralbell R. Total body irradiation before allogeneic bone marrow transplant: is more dose better? Int J Radiat Oncol Biol Phys 2001; 49: 1071-1077.
12. Hansen JA, Gooley TA, Martin PJ et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukaemia. New Engl J Med 1998; 338: 926-968.
13. Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukaemia: strong graft-versus-leukaemia effect and risk factors determining outcome. Blood 2001; 97: 1572-1577.
14. Bacigalupo A, Zikos P, Van Lint MT et al. Allogeneic bone marrow for peripheral blood cell transplants in adults with hematologic malignancies: a single center experience. Exp Hematol 1998; 26: 409-414.
15. Corvò R, Paoli G, Barra S et al. Total body irradiation correlates with chronic graft-versus-host disease and affects prognosis of patients with acute lymphoblastic leukaemia receiving an HLA-identical allogeneic bone marrow transplant. Int J Radiat Oncol Biol Phys 1999; 43: 497-503.
16. Bacigalupo A, Bregante S, Tedone E et al. Combined foscarnet-gancyclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation. Transplantation 1996; 62: 376-380
17. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-460.
18. Curtis R, Rowlings PA, Deeg J et al. Solid cancers after bone marrow transplantation. New Engl J Med 1997; 336: 897-904.
19. Frassoni F, Scarpati D, Bacigalupo A et al. The effects of total body irradiation dose and chronic graft-versus-host disease on leukemic relapse after allogeneic bone marrow transplantation. Br J Haematol 1989; 73: 211-216.
20. Socie G, Devergie A, Girinsky T et al. Total body irradiation in acute myeloid leukaemia and chronic leukaemia. Int J Radiat Oncol Biol Phys 1991; 20: 397-404.
21. Hows J, Bradley B, Gore S et al. Prospective evaluation of unrelated donor bone marrow transplantation. Bone Marrow Transplant 1993; 12: 371-380.
22. Fowler JF. The linear quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-684.
23. Evans RG. Biologic and physical principles of total body irradiation for allogeneic and autologous bone marrow transplantation in childhood with leukaemia and lymphoma. In: Cassady RJ (ed.). Radiation Oncology in Paediatric Oncology. Springer-Verlag: Berlin, 1994, pp 115-122.